Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Naftopidil

Naftopidil

pharmaceutical raw materials
Naftopidil structure

Naftopidil 

structure
  • CAS No:

    57149-07-2

  • Formula:

    C24H28N2O3

  • Chemical Name:

    Naftopidil

  • Synonyms:

    1-Piperazineethanol,4-(2-methoxyphenyl)-α-[(1-naphthalenyloxy)methyl]-;4-(2-Methoxyphenyl)-α-[(1-naphthalenyloxy)methyl]-1-piperazineethanol;Naftopidil;(±)-Naftopidil;Naftopil;3-[4-(2-Methoxyphenyl)piperazinyl]-1-naphthyloxypropan-2-ol;Avishot;Flivas;KT 611;1-[4-(2-Methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol;1-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-3-(naphthalen-1-yloxy)-propan-2-ol;132295-16-0;428520-36-9

  • Categories:

    Active Pharmaceutical Ingredients  >  Circulatory System Drugs

Description

Naftopidil (Flivas), a selective α1-adrenergic receptor antagonist or alpha blocker, is an antihypertensive drug.Target: α1-Adrenergic ReceptorNaftopidil significantly improved the overall international prostatic symptom score ; from 19.2±7.9 to 11.7±5.8 in the M group and from 19.4±6.4 to 12.3±6.8 in the E group (p<0.0001), QOL score from 4.9±0.8 to 3.2±1.4 in the M group and from 5.0±0.8 to 3.6±1.3 in the E group (p<0.0001), and OAB symptom score from 7.8±2.6 to 5.0±2.5 in the M group


Naftopidil is a member of piperazines.|Naftopidil has been investigated for the treatment of Disorder of Urinary Stent.

Naftopidil Basic Attributes

392.49

392.49

1308068-626-2

759293

DTXSID5045176

2942000000

Characteristics

45.2

4.1

white solid

1.2±0.1 g/cm3

125-126 °C

602.8°C at 760 mmHg

318.3±31.5 °C

1.619

methanol: >10 mg/mL

Store at RT

LD50 in mice, rats (g/kg): 1.3, 6.4 orally (Himmel)

Safety Information

3077

3

TL9336500

P201, P202, P261, P264, P271, P280, P281, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501

H315

|Warning|H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]|P201, P202, P281, P308+P313, P405, and P501|Aggregated GHS information provided by 2 companies from 2 notifications to the ECHA C&L Inventory.

Drug Information

Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)|Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)|A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)|Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)

1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol

Naftopidil Use and Manufacturing

Methods of Manufacturing

Reference 2-((1-naphthyloxy)methyl)4-(2-methoxyphenyl) piperazine (100 mg, 0.50 mmol) in ethanol (1 ml) solution of oxirane (95 μL, 0.60 mmol) was added at room temperature. The mixture was stirred refluxing 1. The reaction mixture was concentrated under reduced pressure. (RS)- (199 mg, 100percent) of crude product was purified by silica gel column chromatography to give naftopidil.

Uses

antihypertensive, alpha-blocker, 5HT1a agonist

Computed Properties

Molecular Weight:392.5
XLogP3:4.1
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:7
Exact Mass:392.20999276
Monoisotopic Mass:392.20999276
Topological Polar Surface Area:45.2
Heavy Atom Count:29
Complexity:483
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Extract from the above information

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • SYN-TECH CHEM AND PHARM CO LTD

    United States United States
    Active
  • Hainan Simcere Pharmaceutical Co., Ltd.

    China China
    Active
  • GUIZHOU-EAKAN Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Naftopidil

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.